Sorafenib enhances the therapeutic efficacy of rapamycin in colorectal cancers harboring oncogenic KRAS and PIK3CA-Reference-Cited by-同舟云学术

Sorafenib enhances the therapeutic efficacy of rapamycin in colorectal cancers harboring oncogenic KRAS and PIK3CA

Published:2012-06-13 Issue:9 Volume:33 Page:1782-1790
ISSN:1460-2180
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Gulhati Pat,Zaytseva Yekaterina Y,Valentino Joseph D,Stevens Payton D,Kim Ji Tae,Sasazuki Takehiko,Shirasawa Senji,Lee Eun Y,Weiss Heidi L,Dong Jianli,Gao Tianyan,Evers B. Mark

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/33/9/1782/17291346/bgs203.pdf

Reference30 articles.

1. The phosphatidylinositol 3ʹ-kinase p85alpha gene is an oncogene in human ovarian and colon tumors.;Philp;Cancer Res.,2001

2. AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis.;Roy;Carcinogenesis,2002

3. Defining the role of mTOR in cancer.;Guertin;Cancer Cell,2007

4. High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer.;Simi;Am. J. Clin. Pathol.,2008

5. Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers.;Liu;J. Clin. Endocrinol. Metab.,2008

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of glucose metabolism on PD-L1 expression in sorafenib-resistant hepatocellular carcinoma cells;Scientific Reports;2024-01-19

2. Targeting feedback activation of signaling transduction pathways to overcome drug resistance in cancer;Drug Resistance Updates;2022-12

3. Sorafenib, rapamycin, and venetoclax attenuate doxorubicin-induced senescence and promote apoptosis in HCT116 cells;Saudi Pharmaceutical Journal;2022-01

4. Exploring the Anti-Cancer Mechanism of Novel 3,4′-Substituted Diaryl Guanidinium Derivatives;Pharmaceuticals;2020-12-21

5. Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance);Therapeutic Advances in Medical Oncology;2020-01